<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04889079</url>
  </required_header>
  <id_info>
    <org_study_id>IRB_00142231</org_study_id>
    <nct_id>NCT04889079</nct_id>
  </id_info>
  <brief_title>Assessing Adolescent Use of Nexplanon Over Time: a Prospective, Longitudinal Study</brief_title>
  <official_title>Assessing Adolescent Use of Nexplanon Over Time: a Prospective, Longitudinal Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare Nexplanon decision-making, uptake, satisfaction and&#xD;
      contraceptive outcomes (continuation, switching, discontinuation) over a 12-month period&#xD;
      among adolescents ages 15-18 to adolescents ages 19-24, living in Utah. Data from this study&#xD;
      will provide valuable information for clinical and public health offerings, counseling and&#xD;
      support for Nexplanon use across stages of adolescence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite increasing availability of Nexplanon in the United States, only limited resesarch&#xD;
      exists on Nexplanon use among adolescents, particularly nulliparous adolescents. A Cochrane&#xD;
      systematic review of long-acting contraception use among adolescents in 2017 identified only&#xD;
      four studies that had specifically assessed implant use and continuation among adolescents&#xD;
      [1]. Of these, the majority of studies assessed use postpartum [1]. The majority of research&#xD;
      on adolescent attitudes around and barriers to long-acting reversible contraception has been&#xD;
      conducted on intrauterine devices, rather than implants, and further research is needed to&#xD;
      understand decision-making and behaviors around implant use [2]. Additionally, no studies&#xD;
      have assessed differences in adolescent decision-making by age. While adolescence is&#xD;
      considered ages 10-24 [3], this period is one of substantial change, physically, mentally,&#xD;
      and in stages of life. Contraceptive use can be influenced by all of these [4] and&#xD;
      understanding differences in stages of adolescence could result in meaningful differences in&#xD;
      counseling and support approaches.&#xD;
&#xD;
      The purpose of this study is to compare Nexplanon decision-making, uptake, satisfaction and&#xD;
      contraceptive outcomes (continuation, switching, discontinuation) over a 12-month period&#xD;
      among adolescents ages 15-18 to adolescents ages 19-24, living in Utah. Data from this study&#xD;
      will provide valuable information for clinical and public health offerings, counseling and&#xD;
      support for Nexplanon use across stages of adolescence.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>12-month contraceptive outcomes</measure>
    <time_frame>12-months</time_frame>
    <description>Contraceptive continuation/switching/discontinuation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contraceptive satisfaction</measure>
    <time_frame>12-months</time_frame>
    <description>5-point Likert satisfaction scale</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">255</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Adolescent females, aged 15-18</arm_group_label>
    <description>Adolescents females aged 15-18, who selected a contraceptive implant to prevent pregnancy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adolescent females, aged 19-24</arm_group_label>
    <description>Adolescents females aged 19-24, who selected a contraceptive implant to prevent pregnancy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contraceptive use (continuation/switching/discontinuation)</intervention_name>
    <description>Assessing contraceptive continuation/switching/discontinuation over 12-months</description>
    <arm_group_label>Adolescent females, aged 15-18</arm_group_label>
    <arm_group_label>Adolescent females, aged 19-24</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adolescents living in Utah seeking a contraceptive implant at a participating clinic.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between the ages of 15-24;&#xD;
&#xD;
          -  Not currently pregnant;&#xD;
&#xD;
          -  Planning to avoid pregnancy for the next 12 months;&#xD;
&#xD;
          -  Selecting the contraceptive implant as their contraceptive method of choice;&#xD;
&#xD;
          -  Willing to be contacted via email survey 4 times over 12-months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rebecca Simmons, PhD</last_name>
    <phone>801-213-4989</phone>
    <email>rebecca.simmons@hsc.utah.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Gibson</last_name>
    <phone>801-213-4989</phone>
    <email>marie.gibson@hsc.utah.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Berlan ED, Richards MJ, Vieira CS, Creinin MD, Kaunitz AM, Fraser IS, Edelman A, Mansour D. Best Practices for Counseling Adolescents about the Etonogestrel Implant. J Pediatr Adolesc Gynecol. 2020 Oct;33(5):448-454. doi: 10.1016/j.jpag.2020.06.022. Epub 2020 Jul 2. Review.</citation>
    <PMID>32621879</PMID>
  </reference>
  <reference>
    <citation>Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018 Mar;2(3):223-228. doi: 10.1016/S2352-4642(18)30022-1. Epub 2018 Jan 30.</citation>
    <PMID>30169257</PMID>
  </reference>
  <reference>
    <citation>Downey MM, Arteaga S, Villase√±or E, Gomez AM. More Than a Destination: Contraceptive Decision Making as a Journey. Womens Health Issues. 2017 Sep - Oct;27(5):539-545. doi: 10.1016/j.whi.2017.03.004. Epub 2017 Apr 12.</citation>
    <PMID>28412049</PMID>
  </reference>
  <results_reference>
    <citation>Diedrich JT, Klein DA, Peipert JF. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017 Apr;216(4):364.e1-364.e12. doi: 10.1016/j.ajog.2016.12.024. Epub 2016 Dec 28. Review.</citation>
    <PMID>28038902</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2021</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Rebecca Simmons</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>adolescents</keyword>
  <keyword>contraception</keyword>
  <keyword>contraceptive implant</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

